Global Schizophrenia Treatments Market Size, Status and Forecast 2021-2027

統合失調症治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Schizophrenia Treatments Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR5128
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:92
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥858,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、統合失調症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(非定型抗精神病薬、フェノチアジン抗精神病薬、チオキサンテン、その他の抗精神病薬)、用途別市場規模(病院薬局、ドラッグストア、小売薬局、Eコマース)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・統合失調症治療の市場動向
・企業の競争状況、市場シェア
・統合失調症治療の種類別市場規模(非定型抗精神病薬、フェノチアジン抗精神病薬、チオキサンテン、その他の抗精神病薬)
・統合失調症治療の用途別市場規模(病院薬局、ドラッグストア、小売薬局、Eコマース)
・統合失調症治療の北米市場規模2016-2027(アメリカ、カナダ)
・統合失調症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・統合失調症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・統合失調症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・統合失調症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Johnson and Johnson、Bristol-Myers Squibb、Otsuka、AstraZeneca、Sumitomo Dainippon Pharma、Eli Lilly、Alkermes、Vanda Pharmaceuticals、ALLERGAN、Pfizer)
・結論

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality.
The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schizophrenia.

Market Analysis and Insights: Global Schizophrenia Treatments Market
The global Schizophrenia Treatments market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Schizophrenia Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Schizophrenia Treatments market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Schizophrenia Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Schizophrenia Treatments market.

Global Schizophrenia Treatments Scope and Market Size
Schizophrenia Treatments market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Schizophrenia Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Atypical Antipsychotics
Phenothiazine Antipsychotics
Thioxanthenes
Miscellaneous Antipsychotic Agents

Segment by Application
Hospital Pharmacies
Drug Stores
Retail Pharmacies
E-Commerce

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson and Johnson
Bristol-Myers Squibb
Otsuka
AstraZeneca
Sumitomo Dainippon Pharma
Eli Lilly
Alkermes
Vanda Pharmaceuticals
ALLERGAN

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Schizophrenia Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Atypical Antipsychotics
1.2.3 Phenothiazine Antipsychotics
1.2.4 Thioxanthenes
1.2.5 Miscellaneous Antipsychotic Agents
1.3 Market by Application
1.3.1 Global Schizophrenia Treatments Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.3.5 E-Commerce
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Schizophrenia Treatments Market Perspective (2016-2027)
2.2 Schizophrenia Treatments Growth Trends by Regions
2.2.1 Schizophrenia Treatments Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Schizophrenia Treatments Historic Market Share by Regions (2016-2021)
2.2.3 Schizophrenia Treatments Forecasted Market Size by Regions (2022-2027)
2.3 Schizophrenia Treatments Industry Dynamic
2.3.1 Schizophrenia Treatments Market Trends
2.3.2 Schizophrenia Treatments Market Drivers
2.3.3 Schizophrenia Treatments Market Challenges
2.3.4 Schizophrenia Treatments Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Schizophrenia Treatments Players by Revenue
3.1.1 Global Top Schizophrenia Treatments Players by Revenue (2016-2021)
3.1.2 Global Schizophrenia Treatments Revenue Market Share by Players (2016-2021)
3.2 Global Schizophrenia Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Schizophrenia Treatments Revenue
3.4 Global Schizophrenia Treatments Market Concentration Ratio
3.4.1 Global Schizophrenia Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Schizophrenia Treatments Revenue in 2020
3.5 Schizophrenia Treatments Key Players Head office and Area Served
3.6 Key Players Schizophrenia Treatments Product Solution and Service
3.7 Date of Enter into Schizophrenia Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Schizophrenia Treatments Breakdown Data by Type
4.1 Global Schizophrenia Treatments Historic Market Size by Type (2016-2021)
4.2 Global Schizophrenia Treatments Forecasted Market Size by Type (2022-2027)

5 Schizophrenia Treatments Breakdown Data by Application
5.1 Global Schizophrenia Treatments Historic Market Size by Application (2016-2021)
5.2 Global Schizophrenia Treatments Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Schizophrenia Treatments Market Size (2016-2027)
6.2 North America Schizophrenia Treatments Market Size by Type
6.2.1 North America Schizophrenia Treatments Market Size by Type (2016-2021)
6.2.2 North America Schizophrenia Treatments Market Size by Type (2022-2027)
6.2.3 North America Schizophrenia Treatments Market Size by Type (2016-2027)
6.3 North America Schizophrenia Treatments Market Size by Application
6.3.1 North America Schizophrenia Treatments Market Size by Application (2016-2021)
6.3.2 North America Schizophrenia Treatments Market Size by Application (2022-2027)
6.3.3 North America Schizophrenia Treatments Market Size by Application (2016-2027)
6.4 North America Schizophrenia Treatments Market Size by Country
6.4.1 North America Schizophrenia Treatments Market Size by Country (2016-2021)
6.4.2 North America Schizophrenia Treatments Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Schizophrenia Treatments Market Size (2016-2027)
7.2 Europe Schizophrenia Treatments Market Size by Type
7.2.1 Europe Schizophrenia Treatments Market Size by Type (2016-2021)
7.2.2 Europe Schizophrenia Treatments Market Size by Type (2022-2027)
7.2.3 Europe Schizophrenia Treatments Market Size by Type (2016-2027)
7.3 Europe Schizophrenia Treatments Market Size by Application
7.3.1 Europe Schizophrenia Treatments Market Size by Application (2016-2021)
7.3.2 Europe Schizophrenia Treatments Market Size by Application (2022-2027)
7.3.3 Europe Schizophrenia Treatments Market Size by Application (2016-2027)
7.4 Europe Schizophrenia Treatments Market Size by Country
7.4.1 Europe Schizophrenia Treatments Market Size by Country (2016-2021)
7.4.2 Europe Schizophrenia Treatments Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Schizophrenia Treatments Market Size (2016-2027)
8.2 Asia-Pacific Schizophrenia Treatments Market Size by Type
8.2.1 Asia-Pacific Schizophrenia Treatments Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Schizophrenia Treatments Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Schizophrenia Treatments Market Size by Type (2016-2027)
8.3 Asia-Pacific Schizophrenia Treatments Market Size by Application
8.3.1 Asia-Pacific Schizophrenia Treatments Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Schizophrenia Treatments Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Schizophrenia Treatments Market Size by Application (2016-2027)
8.4 Asia-Pacific Schizophrenia Treatments Market Size by Region
8.4.1 Asia-Pacific Schizophrenia Treatments Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Schizophrenia Treatments Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Schizophrenia Treatments Market Size (2016-2027)
9.2 Latin America Schizophrenia Treatments Market Size by Type
9.2.1 Latin America Schizophrenia Treatments Market Size by Type (2016-2021)
9.2.2 Latin America Schizophrenia Treatments Market Size by Type (2022-2027)
9.2.3 Latin America Schizophrenia Treatments Market Size by Type (2016-2027)
9.3 Latin America Schizophrenia Treatments Market Size by Application
9.3.1 Latin America Schizophrenia Treatments Market Size by Application (2016-2021)
9.3.2 Latin America Schizophrenia Treatments Market Size by Application (2022-2027)
9.3.3 Latin America Schizophrenia Treatments Market Size by Application (2016-2027)
9.4 Latin America Schizophrenia Treatments Market Size by Country
9.4.1 Latin America Schizophrenia Treatments Market Size by Country (2016-2021)
9.4.2 Latin America Schizophrenia Treatments Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Schizophrenia Treatments Market Size (2016-2027)
10.2 Middle East & Africa Schizophrenia Treatments Market Size by Type
10.2.1 Middle East & Africa Schizophrenia Treatments Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Schizophrenia Treatments Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Schizophrenia Treatments Market Size by Type (2016-2027)
10.3 Middle East & Africa Schizophrenia Treatments Market Size by Application
10.3.1 Middle East & Africa Schizophrenia Treatments Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Schizophrenia Treatments Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Schizophrenia Treatments Market Size by Application (2016-2027)
10.4 Middle East & Africa Schizophrenia Treatments Market Size by Country
10.4.1 Middle East & Africa Schizophrenia Treatments Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Schizophrenia Treatments Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Schizophrenia Treatments Introduction
11.1.4 Johnson and Johnson Revenue in Schizophrenia Treatments Business (2016-2021)
11.1.5 Johnson and Johnson Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Schizophrenia Treatments Introduction
11.2.4 Bristol-Myers Squibb Revenue in Schizophrenia Treatments Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Otsuka
11.3.1 Otsuka Company Details
11.3.2 Otsuka Business Overview
11.3.3 Otsuka Schizophrenia Treatments Introduction
11.3.4 Otsuka Revenue in Schizophrenia Treatments Business (2016-2021)
11.3.5 Otsuka Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Schizophrenia Treatments Introduction
11.4.4 AstraZeneca Revenue in Schizophrenia Treatments Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Sumitomo Dainippon Pharma
11.5.1 Sumitomo Dainippon Pharma Company Details
11.5.2 Sumitomo Dainippon Pharma Business Overview
11.5.3 Sumitomo Dainippon Pharma Schizophrenia Treatments Introduction
11.5.4 Sumitomo Dainippon Pharma Revenue in Schizophrenia Treatments Business (2016-2021)
11.5.5 Sumitomo Dainippon Pharma Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Schizophrenia Treatments Introduction
11.6.4 Eli Lilly Revenue in Schizophrenia Treatments Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Alkermes
11.7.1 Alkermes Company Details
11.7.2 Alkermes Business Overview
11.7.3 Alkermes Schizophrenia Treatments Introduction
11.7.4 Alkermes Revenue in Schizophrenia Treatments Business (2016-2021)
11.7.5 Alkermes Recent Development
11.8 Vanda Pharmaceuticals
11.8.1 Vanda Pharmaceuticals Company Details
11.8.2 Vanda Pharmaceuticals Business Overview
11.8.3 Vanda Pharmaceuticals Schizophrenia Treatments Introduction
11.8.4 Vanda Pharmaceuticals Revenue in Schizophrenia Treatments Business (2016-2021)
11.8.5 Vanda Pharmaceuticals Recent Development
11.9 ALLERGAN
11.9.1 ALLERGAN Company Details
11.9.2 ALLERGAN Business Overview
11.9.3 ALLERGAN Schizophrenia Treatments Introduction
11.9.4 ALLERGAN Revenue in Schizophrenia Treatments Business (2016-2021)
11.9.5 ALLERGAN Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Schizophrenia Treatments Introduction
11.10.4 Pfizer Revenue in Schizophrenia Treatments Business (2016-2021)
11.10.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Schizophrenia Treatments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Atypical Antipsychotics
Table 3. Key Players of Phenothiazine Antipsychotics
Table 4. Key Players of Thioxanthenes
Table 5. Key Players of Miscellaneous Antipsychotic Agents
Table 6. Global Schizophrenia Treatments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Schizophrenia Treatments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Schizophrenia Treatments Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Schizophrenia Treatments Market Share by Regions (2016-2021)
Table 10. Global Schizophrenia Treatments Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Schizophrenia Treatments Market Share by Regions (2022-2027)
Table 12. Schizophrenia Treatments Market Trends
Table 13. Schizophrenia Treatments Market Drivers
Table 14. Schizophrenia Treatments Market Challenges
Table 15. Schizophrenia Treatments Market Restraints
Table 16. Global Schizophrenia Treatments Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Schizophrenia Treatments Market Share by Players (2016-2021)
Table 18. Global Top Schizophrenia Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Schizophrenia Treatments as of 2020)
Table 19. Ranking of Global Top Schizophrenia Treatments Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Schizophrenia Treatments Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Schizophrenia Treatments Product Solution and Service
Table 23. Date of Enter into Schizophrenia Treatments Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Schizophrenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Schizophrenia Treatments Revenue Market Share by Type (2016-2021)
Table 27. Global Schizophrenia Treatments Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Schizophrenia Treatments Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Schizophrenia Treatments Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Schizophrenia Treatments Revenue Market Share by Application (2016-2021)
Table 31. Global Schizophrenia Treatments Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Schizophrenia Treatments Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Schizophrenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Schizophrenia Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Schizophrenia Treatments Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Schizophrenia Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Schizophrenia Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Schizophrenia Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Schizophrenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Schizophrenia Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Schizophrenia Treatments Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Schizophrenia Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Schizophrenia Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Schizophrenia Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Schizophrenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Schizophrenia Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Schizophrenia Treatments Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Schizophrenia Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Schizophrenia Treatments Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Schizophrenia Treatments Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Schizophrenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Schizophrenia Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Schizophrenia Treatments Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Schizophrenia Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Schizophrenia Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Schizophrenia Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Schizophrenia Treatments Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Schizophrenia Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Schizophrenia Treatments Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Schizophrenia Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Schizophrenia Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Schizophrenia Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 63. Johnson and Johnson Company Details
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Schizophrenia Treatments Product
Table 66. Johnson and Johnson Revenue in Schizophrenia Treatments Business (2016-2021) & (US$ Million)
Table 67. Johnson and Johnson Recent Development
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Schizophrenia Treatments Product
Table 71. Bristol-Myers Squibb Revenue in Schizophrenia Treatments Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Otsuka Company Details
Table 74. Otsuka Business Overview
Table 75. Otsuka Schizophrenia Treatments Product
Table 76. Otsuka Revenue in Schizophrenia Treatments Business (2016-2021) & (US$ Million)
Table 77. Otsuka Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Schizophrenia Treatments Product
Table 81. AstraZeneca Revenue in Schizophrenia Treatments Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Sumitomo Dainippon Pharma Company Details
Table 84. Sumitomo Dainippon Pharma Business Overview
Table 85. Sumitomo Dainippon Pharma Schizophrenia Treatments Product
Table 86. Sumitomo Dainippon Pharma Revenue in Schizophrenia Treatments Business (2016-2021) & (US$ Million)
Table 87. Sumitomo Dainippon Pharma Recent Development
Table 88. Eli Lilly Company Details
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Schizophrenia Treatments Product
Table 91. Eli Lilly Revenue in Schizophrenia Treatments Business (2016-2021) & (US$ Million)
Table 92. Eli Lilly Recent Development
Table 93. Alkermes Company Details
Table 94. Alkermes Business Overview
Table 95. Alkermes Schizophrenia Treatments Product
Table 96. Alkermes Revenue in Schizophrenia Treatments Business (2016-2021) & (US$ Million)
Table 97. Alkermes Recent Development
Table 98. Vanda Pharmaceuticals Company Details
Table 99. Vanda Pharmaceuticals Business Overview
Table 100. Vanda Pharmaceuticals Revenue in Schizophrenia Treatments Business (2016-2021) & (US$ Million)
Table 101. Vanda Pharmaceuticals Recent Development
Table 102. ALLERGAN Company Details
Table 103. ALLERGAN Business Overview
Table 104. ALLERGAN Schizophrenia Treatments Product
Table 105. ALLERGAN Revenue in Schizophrenia Treatments Business (2016-2021) & (US$ Million)
Table 106. ALLERGAN Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Schizophrenia Treatments Product
Table 110. Pfizer Revenue in Schizophrenia Treatments Business (2016-2021) & (US$ Million)
Table 111. Pfizer Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Schizophrenia Treatments Market Share by Type: 2020 VS 2027
Figure 2. Atypical Antipsychotics Features
Figure 3. Phenothiazine Antipsychotics Features
Figure 4. Thioxanthenes Features
Figure 5. Miscellaneous Antipsychotic Agents Features
Figure 6. Global Schizophrenia Treatments Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. E-Commerce Case Studies
Figure 11. Schizophrenia Treatments Report Years Considered
Figure 12. Global Schizophrenia Treatments Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Schizophrenia Treatments Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Schizophrenia Treatments Market Share by Regions: 2020 VS 2027
Figure 15. Global Schizophrenia Treatments Market Share by Regions (2022-2027)
Figure 16. Global Schizophrenia Treatments Market Share by Players in 2020
Figure 17. Global Top Schizophrenia Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Schizophrenia Treatments as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Schizophrenia Treatments Revenue in 2020
Figure 19. Global Schizophrenia Treatments Revenue Market Share by Type (2016-2021)
Figure 20. Global Schizophrenia Treatments Revenue Market Share by Type (2022-2027)
Figure 21. North America Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Schizophrenia Treatments Market Share by Type (2016-2027)
Figure 23. North America Schizophrenia Treatments Market Share by Application (2016-2027)
Figure 24. North America Schizophrenia Treatments Market Share by Country (2016-2027)
Figure 25. United States Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Schizophrenia Treatments Market Share by Type (2016-2027)
Figure 29. Europe Schizophrenia Treatments Market Share by Application (2016-2027)
Figure 30. Europe Schizophrenia Treatments Market Share by Country (2016-2027)
Figure 31. Germany Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Schizophrenia Treatments Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Schizophrenia Treatments Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Schizophrenia Treatments Market Share by Region (2016-2027)
Figure 41. China Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Schizophrenia Treatments Market Share by Type (2016-2027)
Figure 49. Latin America Schizophrenia Treatments Market Share by Application (2016-2027)
Figure 50. Latin America Schizophrenia Treatments Market Share by Country (2016-2027)
Figure 51. Mexico Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Schizophrenia Treatments Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Schizophrenia Treatments Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Schizophrenia Treatments Market Share by Country (2016-2027)
Figure 57. Turkey Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Schizophrenia Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Johnson and Johnson Revenue Growth Rate in Schizophrenia Treatments Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Schizophrenia Treatments Business (2016-2021)
Figure 62. Otsuka Revenue Growth Rate in Schizophrenia Treatments Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Schizophrenia Treatments Business (2016-2021)
Figure 64. Sumitomo Dainippon Pharma Revenue Growth Rate in Schizophrenia Treatments Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in Schizophrenia Treatments Business (2016-2021)
Figure 66. Alkermes Revenue Growth Rate in Schizophrenia Treatments Business (2016-2021)
Figure 67. Vanda Pharmaceuticals Revenue Growth Rate in Schizophrenia Treatments Business (2016-2021)
Figure 68. ALLERGAN Revenue Growth Rate in Schizophrenia Treatments Business (2016-2021)
Figure 69. Pfizer Revenue Growth Rate in Schizophrenia Treatments Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[統合失調症治療の世界市場規模・現状・予測2021年-2027年] (Global Schizophrenia Treatments Market Size, Status and Forecast 2021-2027 / QY21APR5128)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆